期刊文献+

腹腔镜手术和开腹手术在穿孔性阑尾炎患者中的疗效及安全性观察 被引量:3

Efficacy and safety of laparoscopic surgery and laparotomy in perforated appendicitis
下载PDF
导出
摘要 目的:观察腹腔镜手术和开腹手术在穿孔性阑尾炎患者中的疗效及安全性。方法:选取100例穿孔性阑尾炎患者,按照随机数表法分为对照组和研究组,每组50例,对照组行开腹阑尾切除术治疗,研究组行腹腔镜手术治疗。结果:研究组在术后10 h、20 h、30 h的VAS评分均明显低于对照组(P<0.05);术后研究组的CRP、PCT、IL-6的水平均明显低于对照组(P<0.05);研究组术后不良反应总发生率明显低于对照组(P<0.05)。结论:腹腔镜手术治疗穿孔性阑尾炎具有创伤小、安全性高的显著优势,利于患者恢复。 Objective To observe efficacy and safety of laparoscopic surgery and laparotomy in patients with perforated appen-dicitis. Methods: 100 cases of perforated appendicitis were selected and randomly divided into two groups, 50 cases in each group.The control group underwent open appendectomy, while the study group was given laparoscopic surgery treatment. Results: The VASscores of the study group 10h, 20h and 30h after the operation were lower than those of the control group (P〈0. 05). The levels ofCRP, PCT and IL-6 in the study groupafter the operation were much lower than those in the control group (P〈0. 05). Further, thepostoperative adverse reaction incidence of the study group was lower than those of the control group (P〈0. 05). Conclusions: Laparo-scopic surgery in the treatment of perforated appendicitis is less invasive and safe, and can promote the patients' rehabilitation.
作者 刘永波 LIU Yongbo(People's Hospital of Zhengzhou, Zhengzhou Henan 450003, Chin)
机构地区 郑州人民医院
出处 《中国民康医学》 2017年第23期12-13,27,共3页 Medical Journal of Chinese People’s Health
关键词 腹腔镜下阑尾切除术 开腹阑尾切除术 穿孔性阑尾炎 Laparoscopic appendectomy Open appendectomy Perforated appendicitis
  • 相关文献

参考文献5

二级参考文献54

  • 1邓辉,艾力甫.α 1b-干扰素佐治毛细支气管炎55例疗效观察[J].中外医疗,2008,27(26):58-59. 被引量:4
  • 2刘向萍,崔文强.重组人干扰素α-1b治疗小儿毛细支气管炎100例[J].第四军医大学学报,2005,26(B12):34-34. 被引量:8
  • 3李正兰,叶侃.运德素雾化吸入治疗毛细支气管炎[J].现代生物医学进展,2007,7(6):958-959. 被引量:10
  • 4沈晓明,王卫平.儿科学[M].北京:人民卫生出版社,2009.102.
  • 5胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 6吴瑞萍,胡亚美,江载芳.诸福棠实用儿科学[M].第7版.北京:人民卫生出版社,2002:1171-1204.
  • 7胡亚美,江载芳.诸福棠实用儿科学[M].第7版.北京:人民卫生出版社,2003:1200.
  • 8Schauer U, Hofljan S, Rothoeft T, et al. Severe respiratory ayncytial virus infections and reduced interferon-gamma generation in vitro[J]. Clin Exp Immunol, 2004,138 (1) : 102-109.
  • 9Joshi P, Shaw A, Kakakios A, et al. Interferon-gamma levels in nasohparyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections[J]. Clin Exp Alergy, 2003,131(1) : 142-147.
  • 10Graham B S. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development[J].Immunol Rev,2011,239(1):149-166.

共引文献174

同被引文献18

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部